NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
批准号:
10357862
负责人:
Konstantin H. Dragnev
金额:
$17.25万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-03-15 至 2025-02-28
关键词:
AddressAdolescent and Young AdultAdultAdvanced Malignant NeoplasmAmerican College of Radiology Imaging NetworkBackBasic ScienceCancer CenterCancer PatientCancer and Leukemia Group BCaringCatchment AreaClinicalClinical Cancer CenterClinical OncologyClinical ResearchClinical TreatmentClinical TrialsClinical Trials Cooperative GroupCollaborationsCombined Modality TherapyComprehensive Cancer CenterConduct Clinical TrialsConsentDevelopmentDiagnosisDiagnosticDiseaseEastern Cooperative Oncology GroupEligibility DeterminationEngineeringEnrollmentEvaluationFacultyFundingFunding OpportunitiesFutureGeographic LocationsGeographyGoalsHealthHealth systemImageImmunologicsImmunologyImmunotherapeutic agentIndustryInfrastructureInstitutionInterdisciplinary StudyInterventionKnowledgeLaboratoriesLeadLeadershipLebanonMalignant Childhood NeoplasmMalignant NeoplasmsMedical centerMissionModalityMolecularMolecular TargetMonitorMulti-Institutional Clinical TrialNCI Center for Cancer ResearchNational Cancer InstituteNational Clinical Trials NetworkNew EnglandNew HampshireNorris Cotton Cancer CenterNursing ResearchOncologyOncology GroupOperative Surgical ProceduresPatient CarePatientsPerformancePhasePositioning AttributePreventivePrincipal InvestigatorProcessProtocols documentationRadiation therapyRandomizedRecording of previous eventsReportingRequest for ApplicationsResearchResearch PersonnelResource SharingRuralSchoolsScienceScientistServicesSiteSpecial PopulationSystemTarget PopulationsTestingTherapeuticTranslatingTranslational ResearchUnderserved PopulationVermontanticancer researchbasecancer carecancer clinical trialcancer genomicscancer imagingcancer therapycancer typeclinical applicationcollegecommunity based practicedesigninnovationinterestmedical schoolsmedical specialtiesmembermultidisciplinarymultimodalitynoveloperationpatient populationphase III trialpreventprogramsrare cancerresponsescreeningsymposiumtargeted treatmenttreatment trialtumor
中文摘要
项目总结/摘要
诺里斯棉花癌症中心(NCCC),两者的癌症相关活动的基石
达特茅斯学院,包括其盖泽尔医学院,和达特茅斯希区柯克健康,
将作为主要学术参与者参加NCI的国家临床试验网络
绝佳的价钱NCCC在国家合作组临床试验中有着悠久的领导历史,
回到作为CALGB的运营中心,最近又成为
肿瘤临床试验联盟、NRG、COG和ECOG/ACRIN。作为唯一的国家癌症研究所-
在北方新英格兰指定的综合癌症中心,NCCC目前服务
每年有超过5,000名新病人和30,000名返回的癌症病人。NCCC是专业的
佛蒙特州和新罕布什尔州的学术中心,锚定了17个社区为基础的网络
该地区的实践场所,并接受罕见和晚期癌症的转诊,目标是
从一个大的地理集水区招募创新临床试验的人口。
在达特茅斯,NCCC有一个临床研究的中央办公室(OCR),协调全面的
参与所有临床试验。NCCC打算全面参与所有活动
国家反恐网络的活动,扩大其先前对参与联盟的关注。NCCC研究者
积极参与许多NCTN运营中心委员会,促进双向整合
将NCCC概念纳入NCTN,而NCTN的研究将无缝纳入
NCCC试验组合。我们预计将有55名知情同意的高性能受试者
治疗试验的干预和20例筛选受试者仅累积治疗或
成像试验。卫生署的护理分为17个指定的跨学科疾病为基础的
每周14个小组,为新病人汇集所有相关专业
定期评估临床试验入组资格的会议。NCCC
分配到这些临床肿瘤组(COG)的研究护士负责
保持团队了解可用的试验,以及NCCC临床试验管理系统
(Velos eResearch)提供了跟踪当前注册的团队报告。虽然最高
优先考虑将NCCC科学转化为临床应用,达特茅斯的规模排除了
大多数单一机构研究和国家合作组试验优先于
行业发起的研究,以履行NCCC的临床研究使命。
英文摘要
Project Summary/Abstract
Norris Cotton Cancer Center (NCCC), the keystone of the cancer-related activities of both
Dartmouth College, including its Geisel School of Medicine, and Dartmouth-Hitchcock Health,
will participate in the NCI's National Clinical Trials Network as a Lead Academic Participating
Site. NCCC has a long history of leadership in national cooperative group clinical trials, dating
back to serving as an operating center for CALGB, and more recently as a main member of the
Alliance for Clinical Trial in Oncology, NRG, COG, and ECOG/ACRIN. As the only NCI-
designated Comprehensive Cancer Center in northern New England, NCCC currently serves
annually over 5,000 new patients and 30,000 returning cancer patients. NCCC is the specialty
academic center for Vermont and New Hampshire, anchoring a network of 17 community-based
practice sites across the region and receiving referrals of rare and advanced cancers, the target
population for enrollment on innovative clinical trials, from a large geographic catchment area.
Within Dartmouth, NCCC has a central Office of Clinical Research (OCR) which coordinates full
participation in the entire range of available clinical trials. NCCC intends to participate fully in all
NCTN activities, expanding its prior focus on participation in the Alliance. NCCC investigators
are active in many NCTN Operations Center committees, facilitating a bi-directional integration
of NCCC concepts into the NCTN, while NCTN studies will be seamless incorporated into the
NCCC trial portfolio. We anticipate accrual of 55 consented subjects on high performance
intervention for treatment trials and 20 subjects on screening only accruals for treatment or
imaging trials. Care at DH is organized into 17 designated interdisciplinary disease-based
teams which bring together all relevant specialties, 14 on a weekly basis, for new patient
conferences at which eligibility for enrollment on clinical trials is assessed routinely. NCCC
research nurses assigned to these Clinical Oncology Groups (COGs) are responsible for
keeping the teams informed of available trials, and the NCCC clinical trials management system
(Velos eResearch) provides the teams reports tracking current enrollment. While highest
priority is given to translating NCCC science into clinical application, Dartmouth's size precludes
most single-institution studies, and national cooperative group trials are prioritized ahead of
industry-initiated studies for fulfillment of NCCC's clinical research mission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
“NCI National Clinical Trials Network - Network Lead Academic Participating Sites”
-
批准号:10734623
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2022
-
负责人:Konstantin H. Dragnev
-
依托单位:
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
-
批准号:10116977
-
项目类别:
-
资助金额:$23.17万
-
财政年份:2019
-
负责人:Konstantin H. Dragnev
-
依托单位:
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
-
批准号:9894768
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2019
-
负责人:Konstantin H. Dragnev
-
依托单位:
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
-
批准号:10581527
-
项目类别:
-
资助金额:$43.44万
-
财政年份:2019
-
负责人:Konstantin H. Dragnev
-
依托单位:
Dartmouth Lead Participation in NCI National Clinical Trials Network
-
批准号:8839217
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2014
-
负责人:Konstantin H. Dragnev
-
依托单位:
Dartmouth Lead Participation in NCI National Clinical Trials Network
-
批准号:8605705
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2014
-
负责人:Konstantin H. Dragnev
-
依托单位:
Clinical Protocol and Data Management (CPDM)
-
批准号:10311240
-
项目类别:
-
资助金额:$24.36万
-
财政年份:1997
-
负责人:Konstantin H. Dragnev
-
依托单位:
Clinical Protocol and Data Management (CPDM)
-
批准号:10554300
-
项目类别:
-
资助金额:$24.36万
-
财政年份:1997
-
负责人:Konstantin H. Dragnev
-
依托单位:
Clinical Protocol and Data Management (CPDM)
-
批准号:10165525
-
项目类别:
-
资助金额:$24.36万
-
财政年份:--
-
负责人:Konstantin H. Dragnev
-
依托单位:
海外基金